Investor Presentaiton

Medlab Pathology: a leading Australian privately-owned independent pathology provider with a focus on Sydney and South-East Queensland $ $92.6m FY21 Normalised1 Revenue $ $10.5m FY21 Normalised² EBITDA 2 NATA accredited laboratories 288 Approved Collection Centres Medlab Background Founded in 2001, provides a comprehensive range of pathology services to General Practitioners, Specialists, Medical Centres and Nursing Homes • Medlab's focus is community pathology, with >95% of it's revenue generated through its network of ACCs • The business has grown through organic Approved Collection Centres (ACC) expansion in NSW, and three acquisitions ACC Network Laboratories • Medlab operates a network of 288 ACCS • 205 in NSW: Medlab's footprint is highly complementary to ACL's: Medlab has a very strong presence in Western Sydney, where ACL is comparatively underweight. By comparison, ACL has a stronger position in the Eastern suburbs, the Northern Beaches and the Hills Shire region. Outside Metro Sydney, Medlab's ACCs are mostly located in Wollongong and the South Coast 83 in QLD: The acquisition will provide ACL with an entry platform to Queensland. Medlab's 83 ACCs in QLD equates to 6.5% of ACC's in Queensland spread across South East Queensland with a presence across Brisbane, the Gold Coast and the Sunshine Coast Medlab operates two laboratories: • Auburn in Sydney • Wilston in Brisbane (1) Ex-JobKeeper (2) Pre AASB-16 and JobKeeper, based on PWC Quality of Earnings review 2

View entire presentation